Navigation Links
7 out of 10 women too embarrassed to discuss vaginal dryness and pain with their physician
Date:5/18/2009

The majority of post-menopausal women are uncomfortable talking about vaginal dryness and pain and are reluctant to seek medical help, according to results from a new international survey presented today at the European Congress on Menopause in London. Results from the survey show that over a third (39 percent) of post-menopausal women experience these symptoms of vaginal atrophy and 40 percent of women who have recently experienced vaginal dryness and pain said it interferes with their sex life, yet seven out of ten would not discuss the problem with their physician (only 30 percent of women would consider talking to a gynaecologist, and only 29 percent would consider talking to a GP).

This reluctance to discuss the problem means a quarter would wait for over a year before finally contacting their physician. Additionally, more than a third of those surveyed did not know there are local treatments available.

"The results of this survey really highlight my experiences of treating menopausal women and in my practice in Italy it is even worse. I see many women who have vaginal dryness and pain post-menopause, and the most alarming aspect is that they wait for so long, with only 17 percent of surveyed women taking a treatment to counteract these symptoms." said Dr. Rossella Nappi, Director of the Gynecological Endocrinology & Menopause Unit at the Maugeri Foundation, University of Pavia, Italy. "In addition to the physical pain that affects the women, there is an emotional impact on them and their partner as well, and it is difficult for physicians to break the ice on such a sensitive issue. There is definitely a taboo factor involved as the survey shows that, of those who have experienced vaginal dryness and pain, 47 percent would rather speak to a female physician than a male physician about the problem."

Local symptoms such as painful intercourse, vaginal dryness, itching, burning, and soreness are caused, like other menopausal symptoms, by the gradual decline of oestrogen production in ovaries.

Despite the survey highlighting that so many women delay seeking treatment, it does show that 67 percent of those who have had or are currently taking treatment experience improvements, including an improved quality of life, a return to normal sexual activity, and an improvement in the relationship with their partner.

"The survey results highlight the need for doctors to be pro-active in addressing this taboo head-on by discussing vaginal health with their patients. In addition, I also strongly urge women experiencing vaginal dryness and pain to discuss the issue, as ignoring these symptoms may also lead to more serious long-term urogenital problems. Vaginal dryness and pain don't need to be considered as a natural part of growing older and effective treatment options, such as vaginal oestrogen tablets, pessaries, creams or rings are available and can easily be prescribed by their healthcare professional." said Professor Henry Burger, Consultant Endocrinologist, Jean Hailes Foundation for Women's Health, Melbourne, Australia.


'/>"/>

Contact: Polly Young
novonordisk@cohnwolfe.com
44-207-331-5365
Novo Nordisk Inc.
Source:Eurekalert

Related medicine news :

1. Program focused on body, mind and spirit helps women with breast cancer cope
2. Mayo Clinic researchers say agent provides treatment option for women with hot flashes
3. Menttium Offers Scholarship Award to Businesswomen Leaders
4. Womens Digital Imaging of Ridgewood First Private Medical Practice in New York Area to Screen With Breast Specific Gamma Imaging (BSGI)
5. CDC: Flu Drugs Should Be 1st Choice for Pregnant Women With Swine Flu
6. Siemens Hearing Celebrates 10th Annual National Womens Health Week
7. Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
8. Southern AIDS Living Quilt Posts 100th Video Patch During National Womens Health Week
9. More Single Women Are Having Babies
10. Influenza pandemic planning needed to assure adequate care for pregnant women and newborns
11. New Study Shows Stresses of Economic Downturn on Womens Relationships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of ... a new solution for Emergency Departments (ED) has been added to their portfolio. ... Department examination rooms, and with a simplified pallet of information available to the ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology: